Sam’s Club pharmacies are now selling Novo Nordisk’s Ozempic and Wegovy for $499 per month, expanding consumer access to the popular GLP-1 drugs used for diabetes and weight loss.
The retailer joins Costco, GoodRx and Novo Nordisk’s NovoCare Pharmacy in offering the same discounted price, according to an Oct. 8 report from USA Today. Wegovy’s list price is $1,349 for a month of doses.
Novo Nordisk is broadening retail access as more insurers expand GLP-1 drug coverage. In 2024, 44% of large employers covered GLP-1 drugs for obesity, up from 41% the year before.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
